J
John P. Shelley
Researcher at Vanderbilt University
Publications - 10
Citations - 23
John P. Shelley is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Medicine & Prostate cancer. The author has an hindex of 2, co-authored 4 publications receiving 12 citations. Previous affiliations of John P. Shelley include University of Alabama at Birmingham.
Papers
More filters
Journal ArticleDOI
Medicaid Expansion and Hospitalization for Ambulatory Care-Sensitive Conditions Among Nonelderly Adults With Diabetes.
Favel L. Mondesir,Meredith L. Kilgore,John P. Shelley,Emily B. Levitan,Lei Huang,Kevin R. Riggs,Maria Pisu,Yufeng Li,Janet M. Bronstein,April A. Agne,Andrea Cherrington +10 more
TL;DR: Increased access to care through Medicaid expansion may improve disease management in nonelderly adults with diabetes, and Medicaid expansion was associated with decreases in proportions of hospitalizations for chronic conditions.
Journal ArticleDOI
Diabetes risk scores for Hispanics living in the United States: A systematic review.
Lucia Juarez,Jeffrey S. Gonzalez,April A. Agne,Andrzej Kulczycki,Gregory Pavela,April P. Carson,John P. Shelley,Andrea Cherrington +7 more
TL;DR: Efforts to develop and validate risk prediction models in Hispanic populations in the U.S are needed, particularly given the diversity of thisfast growing population, and healthcare professionals should be aware of the limitations of applying risk scores developed for the general population on Hispanics.
Journal ArticleDOI
Primary care visits and ambulatory care sensitive diabetes hospitalizations among adult Alabama Medicaid beneficiaries.
Janet M. Bronstein,Lei Huang,John P. Shelley,Emily B. Levitan,Caroline A. Presley,April A. Agne,Favel L. Mondesir,Kevin R. Riggs,Maria Pisu,Andrea Cherrington +9 more
TL;DR: In this paper, the authors describe patterns of care use for Alabama Medicaid adult beneficiaries with diabetes and the association between primary care utilization and ambulatory care sensitive (ACS) diabetes hospitalizations.
Posted ContentDOI
Incorporating Genetic Determinants of Prostate-Specific Antigen Levels Improves Prostate Cancer Screening
Linda Kachuri,Thomas J. Hoffmann,Sophie I. Berndt,John P. Shelley,Kerry Schaffer,Mitchell J. Machiela,N. D. Freadman,W.Y. Huang,S. Li,Ryder L. Easterlin,Phyllis J. Goodman,Cathee Till,Ian M. Thompson,Hans Lilja,Stephen K. Van Den Eeden,Stephen J. Chanock,C. Haiman,David V. Conti,Robert J. Klein,Jonathan D. Mosley,Rebecca E. Graff,J. Witte +21 more
TL;DR: Genetically adjusted PSA was more predictive of aggressive prostate cancer than unadjusted PSA and improved detection of aggressive disease when combined with a prostate cancer PGS, and it was shown that PSA-related selection bias distorts genetic associations with prostate cancer and hampers PGS performance.